Professor of Clinical Medicine
Infectious Diseases- Fresno
+1 559 499-6484
Naiel N. Nassar, MD, FACP
Infectious Diseases Division Director/Program Director
Antibiotic Stewardship Director
Professor of Clinical Medicine, UCSF
Naiel Nassar, M.D., specializes in infectious diseases. He is board certified in Internal Disease and Infectious Disease. His fellowship training was completed at the University of California, Davis.
He was appointed as a faculty member in the Division of Infectious Diseases and the Medical Director of the Center for AIDS Research, Education and Services (CARES) in Sacramento.
Publications
Does nicotine impact tramadol abuse? Insights from neurochemical and neurobehavioral changes in mice.
Neurotoxicology
Angiotensin 1-7 ameliorates 6-hydroxydopamine lesions in hemiparkinsonian rats through activation of MAS receptor/PI3K/Akt/BDNF pathway and inhibition of angiotensin II type-1 receptor/NF-κB axis.
Biochemical pharmacology
Nanopyroxene Grafting with β-Cyclodextrin Monomer for Wastewater Applications.
ACS applied materials & interfaces
Fixed-bed column studies of total organic carbon removal from industrial wastewater by use of diatomite decorated with polyethylenimine-functionalized pyroxene nanoparticles.
Journal of colloid and interface science
The Ying and Yang of Adenosine A1 and A2A Receptors on ERK1/2 Activation in a Rat Model of Global Cerebral Ischemia Reperfusion Injury.
Molecular neurobiology
Octreotide ameliorates inflammation and apoptosis in acute and kindled murine PTZ paradigms.
Naunyn-Schmiedeberg's archives of pharmacology
The effect of the nanosize on surface properties of NiO nanoparticles for the adsorption of Quinolin-65.
Physical chemistry chemical physics : PCCP
UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO.
Leukemia
Maghemite nanosorbcats for methylene blue adsorption and subsequent catalytic thermo-oxidative decomposition: Computational modeling and thermodynamics studies.
Journal of colloid and interface science
A man with oral lesions, constipation and back pain.
International journal of STD & AIDS
Enhanced efficacy and reduced side effects of diazepam by kava combination.
Journal of advanced research
Time to virological failure with atazanavir/ritonavir and lopinavir/ritonavir, with or without an H2-receptor blocker, not significantly different in HIV observational database study.
International journal of STD & AIDS
Abacavir sulfate/lamivudine/zidovudine fixed combination in the treatment of HIV infection.
Expert opinion on pharmacotherapy
Comparison of efficacy of efavirenz and nevirapine: lessons learned for cohort analysis in light of the 2NN Study.
HIV clinical trials
Comparison of symptoms of influenza A with abacavir-associated hypersensitivity reaction.
International journal of STD & AIDS
Comparison of nevirapine- and efavirenz-containing antiretroviral regimens in antiretroviral-naïve patients: a cohort study.
HIV clinical trials
Trizivir.
Expert opinion on pharmacotherapy
Coordinated community programs for HIV prevention among intravenous-drug users--California, Massachusetts.
MMWR. Morbidity and mortality weekly report